Search
for
Sort by
Research 91–120 of 1000+
- Interval training and cardiometabolic health in reproductive-aged females
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- (379) The Effect of 5-α Reductase Inhibitor on Male Reproductive Function
- SAT-279 The Effect of Chronic 5-alpha Reductase Inhibition on Clinically Apparent and Silent Cardiovascular Events
- Nanotechnological Interventions and Mechanistic Insights into Wound-Healing Events
- Genome-wide detection of RNA editing events during the hair follicles cycle of Tianzhu white yak
- Association of Frailty Index with Clinical BPH Progression and Serious Adverse Events: the MTOPS Trial
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
- Comparative effects of finasteride and minoxidil on the male reproductive organs: A systematic review of in vitro and in vivo evidence
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
- Metabolic, Behavioral, and Reproductive Effects of Vertical Sleeve Gastrectomy in an Obese Rat Model of Polycystic Ovary Syndrome
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Polycystic ovary syndrome
- Towards the validation of endogenous steroid testing in wildlife hair
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- Analysis of the quality, accuracy, and readability of patient information on polycystic ovarian syndrome (PCOS) on the internet available in English: a cross-sectional study
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Hormonal interventions in skin wounds – a mini review
- Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield
- Cemiplimab-Induced Alopecia Areata